| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5873958 | Journal of Stroke and Cerebrovascular Diseases | 2015 | 5 Pages |
Abstract
Age, sex, baseline National Institutes of Health Stroke Scale score, and time to first dose are predictors of functional outcome in the CHIMES study. Stratification by prognosis showed that patients with 2 or more predictors of poorer outcome have better treatment effect with MLC601 than patients with single or no prognostic factor. These results have implications on designing future stroke trials.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Siwaporn MD, Jose C. MD, Deidre A. FRCP, Somchai MD, Carlos L. MD, Chun Fan PhD, Narayanaswamy FRCP, K.S. Lawrence MD, Marie-Germaine MD, Christopher L.H. FRCP, CHIMES Study Investigators CHIMES Study Investigators,